Browse the evidence

Markov models are the dominant methodological framework for economic evaluations of obesity interventions, with 85% of reviewed studies utilizing state-transition models.

When evaluating the long-term cost-effectiveness of obesity treatments, decision-makers should expect and look for Markov modeling. This is the standard approach for comparing interventions like bariatric surgery, pharmacotherapy, and lifestyle changes over a patient's lifetime.

Current Markov models for obesity interventions exhibit significant methodological heterogeneity, particularly in how they model the progression of obesity and its impact on costs and utilities.

When comparing economic evaluations of obesity treatments, be aware that different studies use different structures (direct BMI-to-cost vs. BMI-to-complications). This makes direct comparison difficult. Look for studies that use standardized validation and include a broad spectrum of complications.

Diabetes mellitus (DM) and cardiovascular disease (CVD) are the most frequently modeled obesity-related complications in Markov models, with DM appearing in 15/15 models focusing on complications and CVD in 14/15.

If you are looking at an economic evaluation of an obesity treatment, expect it to focus heavily on preventing diabetes and cardiovascular events. These are the main drivers of long-term cost savings and quality-of-life improvements in these models.

Validation practices in Markov models for obesity interventions are inconsistently reported, with only 43% of models reporting validation, limiting the reliability and comparability of these evaluations.

Be cautious when using economic evaluations of obesity treatments that do not report validation. Only 43% of the models reviewed reported validation, which limits their reliability. Look for studies that use standardized validation guidelines like ISPOR.

Leucine-rich high protein supplementation (50.6 g protein and 6 g leucine daily) does not significantly improve body composition or muscle function in older adults with sarcopenia over a 12-week period, despite upregulating specific gene expression related to ATP production and DNA repair.

For older adults with sarcopenia, taking leucine-rich protein supplements alone for 12 weeks will not significantly increase muscle mass or improve physical function. While it may positively influence gene expression related to energy production, it is not a standalone solution for reversing sarcopenia. To see functional benefits, supplementation should likely be combined with resistance exercise.

Moderate to severe weight change (loss or gain) of ≥5% within a 2-year interval is associated with a significantly increased risk of suicide mortality, exhibiting a reverse J-shaped curve.

If you experience rapid, unintentional weight loss or gain (≥5% in 2 years), it is a significant physiological stress signal. While weight loss is often pursued for health, rapid changes—especially if unexplained by diet/exercise—warrant medical and psychological evaluation to rule out underlying conditions or mental health risks, rather than simply viewing the change as a success or failure.

The Obesity Lifecycle Model demonstrates favorable concordance with observed clinical and quality-of-life outcomes, validating its use for evaluating obesity-related complications and informing healthcare decision making.

Healthcare decision-makers can use the Obesity Lifecycle Model to assess the cost-effectiveness of obesity therapies with confidence, as it has been validated to accurately predict clinical complications and quality-of-life impacts.

Cardiac diastolic function, specifically the E/e' ratio and Left Atrial Volume Index (LAVI), significantly moderates the reduction in relative peak oxygen uptake in Type 2 Diabetes patients.

For T2D patients, standard cardiac checks might miss the root cause of exercise intolerance. If you struggle with exercise despite normal ejection fraction, ask about diastolic function (E/e' ratio). Addressing this through specific training (like high-intensity interval training, as suggested by the authors) may be more effective than generic advice.

Altering shoulder position (flexed vs. extended) during elbow flexion resistance training does not influence regional hypertrophy or maximum strength gains when resistance profiles are matched.

If you are doing biceps curls, it does not matter whether you sit on a preacher bench (shoulder flexed) or lie back on an incline bench (shoulder extended), as long as you are lifting heavy enough to fail around 8-12 reps. Both positions will build muscle and strength equally well. Do not waste time switching exercises to 'target' the long head; just pick one and focus on adding weight over time.

There are significant research gaps regarding the effectiveness of nutritional interventions for underrepresented populations, specifically women, older adults, and Asian populations.

Be aware that most research on muscle hypertrophy interventions focuses on men and Western populations. If you are a woman, older adult, or from an Asian background, the optimal nutritional strategy may differ, and you should consult a professional for personalized guidance.

Using external momentum (cheat repetitions) during single-joint upper body resistance training produces muscle hypertrophy equivalent to strict technique, despite generating significantly higher volume load.

If you are doing single-joint exercises like bicep curls or tricep pushdowns, you don't need to be rigid about 'strict' form to maximize muscle growth. Using 'cheat' reps (adding momentum) allows you to lift more total volume, which resulted in the same muscle growth as strict reps in this study. However, be cautious of joint stress, especially in your back and hips, as momentum can increase injury risk. Use this technique strategically, perhaps at the end of a set, rather than for every rep, to balance gains with safety.

Genotype-based dietary interventions (low-carb vs. low-fat) do not significantly impact weight loss outcomes, suggesting that genotyping alone is not an effective precision medicine approach for weight loss.

Don't pay for expensive genetic testing to tell you whether to eat low-carb or low-fat. Current high-quality evidence shows that your genotype does not predict whether you will lose more weight on one diet versus the other. Focus on finding a dietary pattern you can adhere to consistently that creates a caloric deficit.

Sarcopenia is driven by anabolic resistance, mitochondrial dysfunction, and chronic inflammation, which decouple muscle mass from muscle function.

Understanding that muscle mass and function are different helps explain why you might look stronger but still feel weak. Treating the underlying inflammation and mitochondrial health is as important as building size.

Higher genetically predicted BMI does not increase the risk of cancer mortality.

While higher BMI increases risks for other causes of death, this study did not find a link to cancer mortality.

A structured, virtual, community-based lifestyle intervention using meal replacements and behavioral support achieves weight loss (14-16%) and type 2 diabetes remission (43%) comparable to GLP-1 receptor agonist therapies.

To achieve significant weight loss and potentially reverse type 2 diabetes, consider a structured program that combines a temporary period of meal replacements with long-term behavioral support. Look for programs that offer frequent check-ins, community support, and a clear plan for transitioning back to regular food. This approach can be as effective as newer weight-loss drugs for many people, especially when sustained over 18 months.

Personalized nutrition significantly reduces HbA1c levels compared to standard control diets in adults with type 2 diabetes or prediabetes, with a median mean difference of -0.925%.

For adults with type 2 diabetes or prediabetes, using personalized nutrition strategies that incorporate individual biological data (like gut microbiome or genetic markers) alongside clinical metrics can lead to greater reductions in HbA1c compared to standard dietary advice. While the evidence quality is currently low due to study variability, the approach shows promise for improving glycemic control.

High-intensity circuit training (HICT) produces strength and lean body mass gains equivalent to traditional strength training (TS) in trained women when sets are taken close to muscular failure, while significantly reducing total session time.

If you are a trained woman looking to save time, try High-Intensity Circuit Training. Perform 3 sets of 8-15 reps for each exercise with short rest (35s) between sets and longer rest (5min) between circuits. Crucially, you must push close to failure (RPE 8-9) to get the same strength and muscle gains as traditional training, but in less time.

Professional athletic status, characterized by structured multidisciplinary training and personalized nutrition, is associated with significantly lower fat mass percentage and higher fat-free mass percentage compared to non-professional athletes.

If you are an athlete, the difference between amateur and pro body composition is significant. Pros have lower fat and more muscle. This isn't just genetics; it's the result of structured, supervised training and personalized diet. If you are not a pro, you can still improve by structuring your training and paying closer attention to your nutrition, even if you can't access a full pro team.

Resistance training significantly improves muscle strength, lean mass, and walking ability in older adults with sarcopenia, with optimal cumulative training volumes of approximately 1,043 minutes for muscle strength and 2,716 minutes for walking ability.

For older adults with sarcopenia, resistance training is the most effective non-pharmacological intervention. Aim for a total training volume of about 1,043 minutes to maximize muscle strength and 2,716 minutes to maximize walking ability. This typically translates to moderate intensity (60-80% of your one-rep max) performed 2-3 times per week. Consistency in total training time is key to reversing muscle loss and improving mobility.

A combined supplementation protocol of creatine, beta-alanine, and caffeine yields superior strength gains (+15.2%) and faster recovery (22 hours) in powerlifters compared to protein supplements or no supplements.

If you are a powerlifter, consider a stack of creatine, beta-alanine, and caffeine. In this study, this combination increased strength by 15.2% and reduced recovery time to 22 hours over 8 weeks, outperforming protein-only supplements and no supplements.

Adapted physical activity (APA) consisting of 3 moderate-intensity sessions per week (20-30 minutes) leads to a statistically significant gain in lean mass (average +0.64%) in hospitalized hematology patients.

For hematology patients, 3 short (20-30 min) moderate sessions per week of light resistance and balance exercises (like yoga or Pilates with light weights) can help preserve or slightly increase muscle mass and reduce fatigue, provided blood counts are monitored and sessions are paused if counts drop too low.

A 12-week nutrition and health canteen-based lifestyle intervention significantly reduces body weight, BMI, and systemic inflammatory biomarkers (IL-6, IL-8, TNF-α, hs-CRP) in middle-aged adults.

To improve weight and reduce inflammation, consider participating in or advocating for structured, healthy collective dining options that limit salt, sugar, and oil while increasing food diversity. Combine this with regular physical activity and health education for best results.

Individualized Virtual Integrative Medicine (IVIM) protocol combined with tirzepatide results in significant weight loss (mean -52.28 lbs at 52 weeks) and high treatment adherence (99.36% achieving >5% weight loss) compared to standard care models.

If you have obesity (BMI >= 30) and are starting tirzepatide, consider a program that offers flexible dosing and regular telehealth support. This approach allows you to adjust your dose based on side effects and progress, rather than following a rigid schedule. Most patients in this study lost significant weight (over 20 lbs on average at 52 weeks) without needing the highest dose, and compounded versions worked just as well as branded ones. The key is consistent support and personalized adjustments.

The Adaptive Ketogenic–Mediterranean Protocol (AKMP) significantly improves insulin resistance, remnant cholesterol, and body composition in adults with overweight or obesity over a 14-week period.

Follow a 14-week plan starting with very low carbs (≤20g/day) and high healthy fats (olive oil, fish) to reset insulin sensitivity and burn fat. After 12 weeks, gradually add back carbs (>100g/day) while maintaining a Mediterranean diet structure. Monitor your progress and adjust protein or calories if weight loss stalls.